posted on 2019-08-02, 04:25authored byJulie Creighton, Helen Heffernan, Julia Howard
Carbapenemase-producing
organisms (CPO) continue to spread around the globe at an alarming rate. People
travelling to, and especially hospitalized in, areas that have high prevalence
rates of MDR organisms (MDRO), such as ESBL- and carbapenemase producing
Gram-negative organisms, are at risk of acquiring these bacteria and subsequent
colonization or infection. In low-prevalence countries, such as New Zealand
(NZ), this risk factor has recently been identified for the first cases of
Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae reported in
NZ. Current reports of CPO in NZ are rare, with a low number of patients found
to have cocarriage of more than two CPO and coproducing strains infrequently encountered.
Here, we report the isolation of seven distinct CPO, together with an
ESBL-producing Pseudomonas aeruginosa and Proteus mirabilis with an ACC-type
AmpC b-lactamase, from a patient recently returned to NZ from a Romanian
hospital.